TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
Corline Biomedical AB
Closing information (x1000 SEK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
25,030
|
23,550
|
7,062 |
Financial expenses |
26
|
0
|
13 |
Earnings before taxes |
-1,809
|
2,329
|
-6,922 |
EBITDA |
-1,691
|
2,385
|
-6,878 |
Total assets |
100,105
|
101,783
|
101,661 |
Current assets |
23,797
|
35,998
|
44,819 |
Current liabilities |
6,789
|
7,194
|
9,427 |
Equity capital |
93,316
|
94,589
|
92,234 |
- share capital |
2,686
![]() |
2,686
![]() |
2,686 |
Employees (average) |
13
|
10
|
9 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
93.2%
|
92.9%
|
90.7% |
Turnover per employee |
1,925
|
2,355
|
785 |
Profit as a percentage of turnover |
-7.2%
|
9.9%
|
-98.0% |
Return on assets (ROA) |
-1.8%
|
2.3%
|
-6.8% |
Current ratio |
350.5%
|
500.4%
|
475.4% |
Return on equity (ROE) |
-1.9%
|
2.5%
|
-7.5% |
Change turnover |
1,480
|
16,488
|
3,366 |
Change turnover % |
6%
|
233% | |
Chg. No. of employees |
3
|
1
![]() |
1 |
Chg. No. of employees % |
30%
|
11% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.